Gemphire Therapeutics Inc. Warrant Agreements
16 Contracts & Agreements
- Amendment to Dong-A Series B Warrant (Filed With SEC on April 14, 2023)
- Amendment to Dong-A Series A Warrant (Filed With SEC on April 14, 2023)
- Form of Dong-A Series B Warrant to purchase shares of common stock (Filed With SEC on November 8, 2022)
- Form of Dong-A Series A Warrant to purchase shares of common stock (Filed With SEC on November 8, 2022)
- Warrant Agency Agreement (Filed With SEC on November 8, 2022)
- Form of Series B Warrant to purchase shares of common stock (Filed With SEC on November 8, 2022)
- Form of Series A Warrant to purchase shares of common stock (Filed With SEC on November 8, 2022)
- Form of Series B Warrant offered hereby (Filed With SEC on November 3, 2022)
- Form of Series A Warrant offered hereby (Filed With SEC on November 3, 2022)
- Form of Warrant offered hereby (Filed With SEC on October 24, 2022)
- Form of Warrant Agency Agreement between the Registrant and American Stock Transfer & Trust Company (Filed With SEC on October 24, 2022)
- Form of Warrant to purchase shares of common stock (Filed With SEC on October 4, 2021)
- Form of Warrant (Filed With SEC on January 21, 2021)
- Form of Placement Agents Warrant (Filed With SEC on April 15, 2020)
- Warrant to Purchase Stock, dated July 31, 2018, by and between Gemphire Therapeutics Inc. and Silicon Valley Bank (Filed With SEC on August 6, 2018)
- GEMPHIRE THERAPEUTICS INC. FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 13, 2017)
